title: Repeated exposure to trace amounts of woodchuck hepadnavirus induces molecularly evident infection and virus-specific T cell response in the absence of serological infection markers and hepatitis.
abstract: Exposure to multiple small doses of hepatitis B virus (HBV) is a frequent occurrence in high-risk groups, including close relatives of infected individuals, primary care givers, and intravenous drug users. It remains uncertain whether such repeated contact may culminate in a symptomatic infection coinciding with hepatitis in individuals not immunoprotected. In this study, we evaluated consequences of multiple exposures to small, liver-nonpathogenic amounts of infectious hepadnavirus in the woodchuck model of hepatitis B. Virus-naïve animals were intravenously injected with 6 weekly doses of 110 DNase digestion-protected virions of woodchuck hepatitis virus (WHV), injected again with 6 weekly 110-virion doses after 7.5 months, and then challenged or not with a liver-pathogenic dose of 1.1 × 10(6) virions of the same inoculum. The data revealed that two rounds of such repeated exposure did not result in serologically evident infection or hepatitis. However, a low-level WHV DNA-positive infection accompanied by a WHV-specific T cell response in the absence of antiviral antibody reactivity was established. The kinetics of the virus-specific and mitogen-induced (generalized) T cell responses and the inability to induce immunoprotection against challenge with a large, liver-pathogenic virus dose were closely comparable to those previously reported for occult infection initiated by a single liver-nonpathogenic dose of WHV. Thus, repeated exposures to small quantities of hepadnavirus induce molecularly evident but serologically silent infection that does not culminate in hepatitis or generate immune protection. The findings imply that the HBV-specific T cell response encountered in the absence of serological markers of infection likely reflects ongoing occult infection.
authors.affiliation: Molecular Virology and Hepatology Research Group, Division of Biomedical Sciences, Memorial University, St. John's, Newfoundland and Labrador, Canada.
authors.forename: Shashi A
authors.initials: SA
authors.lastname: Gujar
authors.forename: Patricia M
authors.initials: PM
authors.lastname: Mulrooney-Cousins
authors.forename: Tomasz I
authors.initials: TI
authors.lastname: Michalak
mesh_terms: D000818:Animals; D058070:Asymptomatic Diseases; D004279:DNA, Viral / Q000302:isolation & purification*; D006509:Hepatitis B / Q000276:immunology / Q000662:veterinary* / Q000821:virology; D017919:Hepatitis B Virus, Woodchuck / Q000276:immunology / Q000472:pathogenicity*; D008392:Marmota; D013601:T-Lymphocytes / Q000276:immunology*
chemical_list: D004279:DNA, Viral